Sleep Apnea Devices Market Research Report 2022
- Report ID: 28305
- Date: Jun, 2022
- Pages: 220
- Category: Healthcare & Pharmaceuticals
The global sleep apnea devices market is expected to grow at a CAGR of 16.6% during the forecast period of 2021 to 2028. North America is the largest market in the global sleep apnea devices market, with a market share of 51.8% as of 2019, followed by Europe and Asia.
The largest share of the North American segment is associated with various driving forces, such as the increasing patient pool of sleep apnea in this region, increasing awareness level among patients and caregivers, and the availability of technologically advanced diagnostic and therapeutic devices. It is estimated that approximately 4% of men and 2% of women suffer from Obstructive Sleep Apnea (OSA) globally.
Also, the rising prevalence of comorbidities (such as drug-resistant hypertension, congestive heart failure, Type 2 diabetes, and stroke, among others) ensures that the global sleep apnea patient pool will grow in the coming years. However, the inadequate reimbursement coverage and patient compliance are perceived to hinder the growth of this market during the forecast period, 2021 to 2028.
In this report, the global sleep apnea devices market is broadly classified on the basis of segments, namely sleep apnea therapeutic devices and sleep apnea diagnostic devices. The sleep apnea therapeutic devices is further segmented based on types, into home sleep testing/portable monitoring, sleep labs, respiratory polygraphs, two-channel screening devices, single channel screening devices, and actigraphy systems. Similarly, the sleep apnea therapeutic devices market is segmented based on types, into Positive Airway Pressure (PAP) devices, masks, adaptive servo-ventilation, airway clearance systems, oxygen devices, and oral appliances. PAP devices segment is the highest contributor in the therapeutic devices market.
Further, the global sleep apnea devices market is segmented based on the geographies into North America, Europe, Asia, and the Rest of the World (RoW). The North American segment dominated the global sleep apnea devices market in 2019, with a share of 51.8%. The major factors contributing to its dominance are the increasing prevalence of sleep apnea, rising awareness among patients and caregivers about sleep apnea, and the rising popularity of oral appliances, among others. According to the American Academy of Sleep Medicine, the number of accredited sleep labs that test for sleep disorder has quadrupled in the past decade, indicative of the increasing awareness levels in this region about sleep apnea.
Europe is the second-largest market for sleep apnea devices, mainly due to the increasing usage of therapeutic devices, growing prevalence of cardiology disorders, increasing prevalence of comorbidities, and presence of well-equipped sleep laboratories. Asia is estimated to be the fastest-growing market in the sleep apnea devices industry as it is projected to grow at a CAGR of 17.7% during the forecast period of 2021 to 2028.
The report has profiled the leading players of this market, along with the developments (New product launches, partnerships, agreements, collaborations, and joint ventures) done by the companies over the past few years and strategies adopted by them to sustain and strengthen their positions in the global sleep apnea devices market. Philips Respironics, a subsidiary of Philips Healthcare (Netherlands); ResMed (U.S.); Compumedics Limited (Australia); Carefusion Corporation (U.S.); Curative Medical, Inc. (U.S.); BMC Medical Co., Ltd. (China); Natus Medical Incorporated (U.S.); Fisher and Paykel Healthcare, Ltd. (New Zealand); DeVilbiss Healthcare (U.S.); Global Medical Holdings, LLC (U.S.); Itamar Medical, Ltd. (U.S.); and Weinmann Medical Devices GmbH & Co. KG (Germany), among others, are some of the key players engaged in this market.
Reasons to Buy the Report:
From an insight perspective, this research report has focused on various levels of analysis—industry analysis (industry trends and PEST analysis), market share analysis of top players, supply chain analysis, and company profiles, which together provide the basic views on the competitive landscape; usage patterns; emerging and high-growth segments of the market; high-growth regions and countries, and their respective regulatory policies; government initiatives; and market drivers, restraints, and opportunities.
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help the firms in garnering a greater share in the global market. Firms purchasing the report could use any one or combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market share.
The report provides insights on the following pointers:
• Product Analysis and development: Detailed insights on upcoming technologies, research & development activities, and new product launches in the global sleep apnea devices market; usage pattern/penetration rate (in-depth trend analysis) of products (segment-wise) and purchasing data; and comprehensive coverage of product approvals, patent analysis, pipeline products, and product recalls.
• Market Development: Comprehensive information about lucrative emerging markets, across geographies, new distribution channels, new clientele base, and different pricing policies.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments decisions in the sleep apnea devices market, along with a detailed description of the related and unrelated diversification pertaining to this market.
• Competitive Assessment: In-depth assessment of market shares and company share analysis of the key players, forecasted till 2028, along with an account of the business strategies and manufacturing capabilities of the leading players.
• Product/Brand Perception Analysis: A comprehensive study of customers’ perception and behavior through our inbuilt social connect tool (digital marketing language) checking the virality and tonality of blogs.
TABLE OF CONTENTS
1 INTRODUCTION .......................................................................................................................................... 12
1.1 OBJECTIVES OF THE STUDY .................................................................................................................................... 12
1.2 MARKET SEGMENTATION & COVERAGE .......................................................................................................... 12
1.3 STAKEHOLDERS ........................................................................................................................................................... 13
2 RESEARCH METHODOLOGY .................................................................................................................... 14
2.1 INTEGRATED ECOSYSTEM OF SLEEP APNEA DEVICES MARKET .............................................................. 14
2.2 ARRIVING AT THE GLOBAL SLEEP APNEA DEVICES MARKET SIZE ......................................................... 15
2.2.1 TOP-DOWN APPROACH .................................................................................................................................15
2.2.2 ASSUMPTIONS ....................................................................................................................................................16
3 EXECUTIVE SUMMARY .............................................................................................................................. 17
4 MARKET OVERVIEW ................................................................................................................................... 19
4.1 INTRODUCTION .......................................................................................................................................................... 19
4.1.1 STAGES OF SLEEP ...............................................................................................................................................19
4.1.1.1 Sleep Cycle ...........................................................................................................................................20
4.1.2 SLEEP DISORDERS ..............................................................................................................................................20
4.1.3 SLEEP APNEA .......................................................................................................................................................21
4.1.4 AN ANATOMY OF A SLEEP APNEA EPISODE ...........................................................................................21
4.1.5 CAUSES ..................................................................................................................................................................22
4.1.5.1 Central Sleep Apnea (CSA) .............................................................................................................22
4.1.5.2 Obstructive Sleep Apnea (OSA) ....................................................................................................22
4.1.6 SIGNS & SYMPTOMS ........................................................................................................................................23
4.1.6.1 Central Sleep Apnea .........................................................................................................................23
4.1.6.2 Obstructive Sleep Apnea(OSA) .....................................................................................................23
4.1.6.3 Signs & Symptoms in Children .....................................................................................................23
4.1.7 RISK FACTORS .....................................................................................................................................................24
4.1.7.1 Central Sleep Apnea .........................................................................................................................24
4.1.7.2 Obstructive Sleep Apnea (OSA) ....................................................................................................24
4.1.8 DIAGNOSIS ...........................................................................................................................................................25
4.1.8.1 Sleep Apnea Diagnosis & Sleep Recording Test ....................................................................25
4.1.9 TREATMENT OPTIONS .....................................................................................................................................25
4.2 SLEEP APNEA DEVICES MARKET: COMPARISON WITH PARENT MARKET .......................................... 27
4.3 MARKET DRIVERS AND INHIBITORS ................................................................................................................... 27
4.4 IMPACT OF REIMBURSEMENT RATES ON SLEEP APNEA THERAPEUTIC MARKET IN THE U.S. .................................................................................................................................................................................... 29
4.5 KEY MARKET DYNAMICS ......................................................................................................................................... 30
Global Sleep Apnea Devices Market - Analysis and Forecast (2013-2019)
Page 3
5 GLOBAL SLEEP APNEA DEVICES MARKET, BY TYPE ........................................................................... 32
5.1 INTRODUCTION .......................................................................................................................................................... 33
5.2 GLOBAL SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE .......................................................... 35
5.2.1 HOME SLEEP TESTING ......................................................................................................................................37
5.3 SLEEP LABS .................................................................................................................................................................... 39
5.4 TWO-CHANNEL SCREENING SYSTEM ................................................................................................................ 40
5.5 SINGLE CHANNEL SCREENING SYSTEMS ......................................................................................................... 41
5.6 SINGLE CHANNEL SCREENING DEVICES, BY TYPE ........................................................................................ 43
5.6.1 HANDHELD PULSE OXIMETER .......................................................................................................................43
5.6.2 FINGERTIP PULSE OXIMETER .........................................................................................................................44
5.6.3 TABLE-TOP PULSE OXIMETER ........................................................................................................................45
5.6.4 WRIST-WORN PULSE OXIMETER ..................................................................................................................45
5.7 ACTIGRAPHY SYSTEMS............................................................................................................................................. 47
5.8 RESPIRATORY POLYGRAPHS .................................................................................................................................. 49
5.9 GLOBAL SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE OF PRODUCT ............................. 51
5.10 CONTINUOUS POSITIVE AIRWAY PRESSURE (CPAP) AND AUTOMATIC POSTIVE AIRWAY PRESSURE(APAP) ....................................................................................................................................... 51
5.10.1 PAP DEVICES ........................................................................................................................................................53
5.10.1.1 CPAP Devices .......................................................................................................................................55
5.10.1.2 APAP Devices ......................................................................................................................................56
5.10.1.3 Bi-level Devices ...................................................................................................................................57
5.10.2 ADAPTIVE SERVO-VENTILATION (ASV) .....................................................................................................58
5.10.3 AIRWAY CLEARANCE SYSTEMS ....................................................................................................................59
5.10.4 OXYGEN DEVICES...............................................................................................................................................60
5.10.4.1 Concentrators ......................................................................................................................................62
5.10.4.2 Home Oxygen Filling Systems ......................................................................................................63
5.10.4.3 Liquid Portable Oxygen ...................................................................................................................64
5.10.5 ORAL APPLIANCE ...............................................................................................................................................65
5.10.5.1 Mandibular Advancement Device (MAD) .................................................................................67
5.10.5.2 Tongue Retaining Device (TRD) ....................................................................................................68
5.10.6 MASKS ....................................................................................................................................................................69
5.10.6.1 Full Face Masks ...................................................................................................................................70
5.3.6.2. Nasal Masks .........................................................................................................................................71
5.3.6.3. Nasal Pillow Masks ............................................................................................................................71
5.3.6.4. Oral Masks ............................................................................................................................................72
6 GLOBAL SLEEP APNEA MARKET, BY GEOGRAPHY ............................................................................. 73
6.1 INTRODUCTION .......................................................................................................................................................... 74
6.2 NORTH AMERICA SLEEP APNEA DEVICES MARKET ..................................................................................... 75
6.2.1 NORTH AMERICA SLEEP APNEA DIAGNOSTIC DEVICES MARKET ...................................................78
6.2.2 NORTH AMERICA SLEEP APNEA THERAPEUTIC DEVICES MARKET .................................................79
Global Sleep Apnea Devices Market - Analysis and Forecast (2013-2019)
Page 4
6.3 EUROPE SLEEP APNEA DEVICES MARKET ......................................................................................................... 80
6.3.1 EUROPE SLEEP APNEA DIAGNOSTIC DEVICES MARKET ......................................................................82
6.3.2 EUROPE SLEEP APNEA THERAPEUTIC DEVICES MARKET ....................................................................83
6.3.3 ASIA SLEEP APNEA DEVICES MARKET ........................................................................................................84
6.3.4 ASIA SLEEP APNEA DIAGNOSTIC DEVICES MARKET.............................................................................87
6.3.5 ASIA SLEEP APNEA THERAPEUTIC DEVICES MARKET ...........................................................................88
6.3.6 REST OF THE WORLD SLEEP APNEA DEVICES MARKET .......................................................................89
6.3.7 REST OF THE WORLD SLEEP APNEA DIAGNOSTIC DEVICES MARKET ...........................................91
6.3.8 REST OF THE WORLD SLEEP APNEA THERAPEUTIC DEVICES MARKET .........................................92
7 GLOBAL SLEEP APNEA DEVICES MARKET: COMPETITIVE LANDSCAPE ........................................ 94
7.1 MARKET SHARES ......................................................................................................................................................... 94
7.1.1 GLOBAL SLEEP APNEA MARKET, BY COMPANY, 2014 .........................................................................94
7.2 GLOBAL SLEEP APNEA DEVICES MARKET: COMPANY SHARE ANALYSIS ............................................ 95
7.3 KEY GROWTH STRATEGIES ..................................................................................................................................... 96
7.4 MERGERS & ACQUISITIONS ................................................................................................................................... 97
7.5 NEW PRODUCT LAUNCH/DEVELOPMENT ....................................................................................................... 97
7.6 PARTNERSHIPS ......................................................................................................................................................... 100
8 SLEEP APNEA DEVICES MARKET, BY COMPANY .............................................................................. 101
8.1 BMC MEDICAL CO., LTD. ....................................................................................................................................... 101
8.1.1 OVERVIEW ......................................................................................................................................................... 101
8.1.2 KEY FINANCIALS .............................................................................................................................................. 101
8.1.3 PRODUCT AND SERVICE OFFERINGS ...................................................................................................... 101
8.1.4 RELATED DEVELOPMENTS ........................................................................................................................... 102
8.2 CAREFUSION CORPORATION ............................................................................................................................. 103
8.2.1 OVERVIEW ......................................................................................................................................................... 103
8.2.2 KEY FINANCIALS .............................................................................................................................................. 103
8.2.3 PRODUCT AND SERVICE OFFERINGS ...................................................................................................... 104
8.2.4 RELATED DEVELOPMENTS ........................................................................................................................... 105
8.3 COMPUMEDICS LIMITED ...................................................................................................................................... 106
8.3.1 OVERVIEW ......................................................................................................................................................... 106
8.3.2 KEY FINANCIALS .............................................................................................................................................. 106
8.3.3 PRODUCT AND SERVICE OFFERINGS ...................................................................................................... 106
8.3.4 RELATED DEVELOPMENTS ........................................................................................................................... 107
8.4 FISHER AND PAYKEL HEALTHCARE LTD. ........................................................................................................ 108
8.4.1 OVERVIEW ......................................................................................................................................................... 108
8.4.2 KEY FINANCIALS .............................................................................................................................................. 108
8.4.3 PRODUCT AND SERVICE OFFERINGS ...................................................................................................... 109
8.4.4 RELATED DEVELOPMENTS ........................................................................................................................... 110
Global Sleep Apnea Devices Market - Analysis and Forecast (2013-2019)
Page 5
8.5 NATUS MEDICAL, INC. ........................................................................................................................................... 111
8.5.1 OVERVIEW ......................................................................................................................................................... 111
8.5.2 KEY FINANCIALS .............................................................................................................................................. 111
8.5.3 PRODUCT AND SERVICE OFFERINGS ...................................................................................................... 111
8.5.4 RELATED DEVELOPMENTS ........................................................................................................................... 112
8.6 PHILIPS RESPIRONICS (SUBSIDIARY OF PHILIPS HEALTHCARE LTD.) ................................................ 113
8.6.1 OVERVIEW ......................................................................................................................................................... 113
8.6.2 KEY FINANCIALS .............................................................................................................................................. 114
8.6.3 PRODUCT AND SERVICE OFFERINGS ...................................................................................................... 114
8.6.4 RELATED DEVELOPMENTS ........................................................................................................................... 115
8.7 RESMED, INC. ............................................................................................................................................................ 117
8.7.1 OVERVIEW ......................................................................................................................................................... 117
8.7.2 KEY FINANCIALS .............................................................................................................................................. 117
8.7.3 PRODUCT AND SERVICE OFFERINGS ...................................................................................................... 118
8.7.4 RELATED DEVELOPMENTS ........................................................................................................................... 120
8.8 WEINMANN MEDICAL DEVICES GMBH & CO. KG ..................................................................................... 122
8.8.1 OVERVIEW ......................................................................................................................................................... 122
8.8.2 KEY FINANCIALS .............................................................................................................................................. 122
8.8.3 PRODUCT AND SERVICE OFFERINGS ...................................................................................................... 122
8.8.4 RELATED DEVELOPMENTS ........................................................................................................................... 124
8.9 AMBULATORY MONITORING, INC. .................................................................................................................. 125
8.9.1 OVERVIEW ......................................................................................................................................................... 125
8.9.2 KEY FINANCIALS .............................................................................................................................................. 125
8.9.3 PRODUCT AND SERVICE OFFERINGS ...................................................................................................... 125
8.9.4 RELATED DEVELOPMENTS ........................................................................................................................... 126
8.10 CLEVEMED .................................................................................................................................................................. 127
8.10.1 OVERVIEW ......................................................................................................................................................... 127
8.10.2 KEY FINANCIALS .............................................................................................................................................. 127
8.10.3 PRODUCT AND SERVICE OFFERINGS ...................................................................................................... 127
8.10.4 RELATED DEVELOPMENTS ........................................................................................................................... 127
8.11 ADVANCED BRAIN MONITORING,INC., ......................................................................................................... 129
8.11.1 OVERVIEW ......................................................................................................................................................... 129
8.11.2 KEY FINANCIALS .............................................................................................................................................. 129
8.11.3 PRODUCT AND SERVICE OFFERINGS ...................................................................................................... 129
8.11.4 RELATED DEVELOPMENTS ........................................................................................................................... 129
8.12 NONIN MEDICAL ..................................................................................................................................................... 130
8.12.1 OVERVIEW ......................................................................................................................................................... 130
8.12.2 KEY FINANCIALS .............................................................................................................................................. 130
8.12.3 PRODUCT AND SERVICE OFFERINGS ...................................................................................................... 130
8.12.4 RELATED DEVELOPMENTS ........................................................................................................................... 132
Global Sleep Apnea Devices Market - Analysis and Forecast (2013-2019)
Page 6
8.13 NOVASOM .................................................................................................................................................................. 133
8.13.1 OVERVIEW ......................................................................................................................................................... 133
8.13.2 KEY FINANCIALS .............................................................................................................................................. 133
8.13.3 PRODUCT AND SERVICE OFFERINGS ...................................................................................................... 133
8.13.4 RELATED DEVELOPMENTS ........................................................................................................................... 133
8.14 ITAMAR MEDICAL, LTD. ......................................................................................................................................... 134
8.14.1 OVERVIEW ......................................................................................................................................................... 134
8.14.2 KEY FINANCIALS .............................................................................................................................................. 134
8.14.3 PRODUCT AND SERVICE OFFERINGS ...................................................................................................... 134
8.14.4 RELATED DEVELOPMENTS ........................................................................................................................... 134
8.15 CADWELL LABORATORIES, INC.......................................................................................................................... 136
8.15.1 OVERVIEW ......................................................................................................................................................... 136
8.15.2 KEY FINANCIALS .............................................................................................................................................. 136
8.15.3 PRODUCT AND SERVICE OFFERINGS ...................................................................................................... 136
8.15.4 RELATED DEVELOPMENTS ........................................................................................................................... 137
8.16 NIHON KOHDEN ...................................................................................................................................................... 138
8.16.1 OVERVIEW ......................................................................................................................................................... 138
8.16.2 KEY FINANCIALS .............................................................................................................................................. 138
8.16.3 PRODUCT AND SERVICE OFFERINGS ...................................................................................................... 139
8.16.4 RELATED DEVELOPMENTS ........................................................................................................................... 139
9 APPENDIX ................................................................................................................................................... 140
9.1 CUSTOMIZATION OPTIONS ................................................................................................................................ 140
9.1.1 EPIDEMIOLOGY DATA ................................................................................................................................... 140
9.1.2 SURGEONS/PHYSICIANS PERCEPTION ANALYSIS .............................................................................. 140
9.2 REGULATORY FRAMEWORK ................................................................................................................................ 140
9.2.1 IMPACT ANALYSIS .......................................................................................................................................... 140
9.2.2 COMPETITIVE INTELLIGENCE: ..................................................................................................................... 140
9.3 RELATED REPORTS .................................................................................................................................................. 141
9.4 INTRODUCING RT: REAL TIME MARKET INTELLIGENCE .......................................................................... 142
9.4.1 RT SNAPSHOTS ................................................................................................................................................ 143
List of Figures
Research methodology is mainly referring to the practical how of any offered piece of research. More specifically, it’s all about how a researcher systematically designs a study in order to assure extremely valid as well as reliable results that ultimately address the targets and objectives of the research.
In any formal research including academic journal, article, dissertation and so on, there will be a special section on a research methodology that mainly describes what, by whom, how to gather as well as how to evaluate the data are provided.
This research methodology has been segmented into following types:
Primary Research:
It is said to be original information that the researchers collect for the crucial purposes of answering the research questions of readers with the help of surveys, observations and experiments.
Secondary Research:
The secondary research is the data that has already been collected by various other researchers in the form of government analysis or scientific studies.
Qualitative Research:
It is descriptive and subjective method irrespective of facts. Both observation and description are essential in this type of research methodology. Its main vision is to analyze knowledge, attitudes, behaviours as well as opinions of people related to the topic of any research. This method has been operated through grounded research, case study and actionable research.
Quantitative Research:
It contains several laboratory experiments, basic surveys, mathematical calculations, simulations and so on. The possible measurement, quantity or amount is considered to be a major factor in the quantitative research methodology.
Clients
